BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
Tianjin LG Bohai Chemical Co. Ltd.
LG Chem Poland Sp. zoo
LG Chem Brasil Ltd.
LG Chem Europe GmbH
BUSINESS STRATEGY: Petrochemical and industrial materials business: Consolidate its foothold
and position itself as a major player in main growing markets such as China
and the U.S. by raising its product quality and cost competitiveness through
enhanced R&D and marketing abilities.
Information and electronic materials business: Focus on rapid developments
of new high-tech products and increasing capacities for its main products
such as rechargeable batteries and display materials.
PRODUCTS ON MARKET: Industrial materials: housing and space materials, living materials,
automobile components, interior decoration materials
LG Life Sciences Ltd.
Chemicals and polymers: PVC and plasticizers, acrylates and e-chemicals,
polyolefin, AVS/PS, engineering plastics, specialty polymers
LG Twin Tower, East Tower, 20, Yoido-dong, Youngdungpo-gu
Seoul, Korea
Phone: +82 2-3773-1114; Fax: +82 2-3773-7012
Web: www.lgls.co.kr; E-mail: hycho@lgls.co.kr
KEY PERSONNEL: Heung-Joon Yang; CEO and Chairman
Han-Yong Yang; VP and CFO
EMPLOYEES: 1,000 employees
HISTORY: Founded in 1947
Established its central research institute in 1979
Started R&D in genetic engineering field in 1981
Acquired Anjin Pharma Corp., Pharmaceutical Division (1989)
Name changed from Lucky, Ltd. (1995)
Demerged from LG Chemical Ltd. into LG Chem Investment, LG Chem and
LG Household & Healthcare (2001)
Spun off from LGCI and name changed to LG Life Sciences (2002)
Factive quinolone antibiotics approved by US FDA (2003)
FACILITIES: Two manufacturing facilities and R&D Park located in South Korea
Pharmaceutical division has two GMP main factories in Iksan and in
Daejeon
STOCK-FINANCIAL HISTORY: Listed on the Korean Stock Exchange
Sales W213,636 (YE 04) compared to W179,037M (YE 03)
Net income W10,073 (YE 04) compared to W3,225M (YE 03)
SUBSIDIARIES/DIVISIONS: Pharmaceutical Division
Agricultural Division
LG Life Sciences India Pvt. Ltd.
LG Life Sciences Poland Sp. Z.o.o
LG Life Sciences Ltd.
Beijing representative office
INVESTMENTS: Elitra Pharmaceuticals
BUSINESS STRATEGY: Enhancement of Efficiency in R&D:
-Focus all-out efforts on candidate materials for developments that have
passed pre-clinical trials
-More systematic promotion of R&D projects
-Solidify alliances with world-class business enterprises
Copyright ©2006 AHC Media ® 221